Cancer Treatment Reviews
Volume 37, Issue 3 , Pages 212-220 , May 2011

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization

  • J.-L. Raoul

      Affiliations

    • Department of Medical Oncology, Centre E. Marquis, INSERM U991 and Rennes University, CS4429, 35042 Rennes, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 299253196; fax: +33 299253108.
  • ,
  • B. Sangro

      Affiliations

    • Liver Unit, Clinica Universitaria de Navarra, Pamplona 31008, Spain
    • Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBERehd), Avenida Pio XII, 36, Pamplona 31008, Spain
  • ,
  • A. Forner

      Affiliations

    • Barcelona Clinic Liver Cancer (BCLC) Group, Liver Unit, Hospital Clinic Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), University of Barcelona, Barcelona, Spain
  • ,
  • V. Mazzaferro

      Affiliations

    • National Cancer Institute, IRCCS Foundation, Via Venezian 1, 20133 Milan, Italy
  • ,
  • F. Piscaglia

      Affiliations

    • Department of Digestive Disease and Internal Medicine, S. Orsola – Malpighi General and University Hospital, Via Albertoni 15, Bologna 40138, Italy
  • ,
  • L. Bolondi

      Affiliations

    • Department of Digestive Disease and Internal Medicine, S. Orsola – Malpighi General and University Hospital, Via Albertoni 15, Bologna 40138, Italy
  • ,
  • R. Lencioni

      Affiliations

    • Pisa University School of Medicine, Cisanello Hospital, Building No. 30C, Suite 197, Via Paradisa 2, IT 56124 Pisa, Italy

Received 4 May 2010 ,Accepted 19 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(10)00131-3

doi: 10.1016/j.ctrv.2010.07.006

Cancer Treatment Reviews
Volume 37, Issue 3 , Pages 212-220 , May 2011